To know or not to know? Attitudes towards receiving genetic information among patients and the general public. by Wolff, Katharina
 
To know or not to know?  
Attitudes towards receiving genetic information 
among patients and the general public. 
Katharina Wolff 










To know or not to know?  
Attitudes towards receiving genetic information 
among patients and the general public. 
Katharina Wolff 






Faculty of psychology, Department of Psychosocial Science 





Table of Contents 
Acknowledgements ................................................................................................................... 7 
List of Papers ............................................................................................................................ 9 
Abstract ................................................................................................................................... 11 
Introduction ............................................................................................................................ 13 
Background ......................................................................................................................... 13 
Research Aims .................................................................................................................... 16 
On Attitudes ........................................................................................................................ 16 
Individual Characteristics Predicting Interest in Genetic Risk Information ............... 17 
Disease Characteristics Predicting Interest in Genetic Risk Information .................... 23 
Methods ................................................................................................................................... 26 
Participants and Procedure ............................................................................................... 26 
Measures ............................................................................................................................. 28 
Dependent variables. ...................................................................................................... 28 
Predictor variables ......................................................................................................... 29 
Statistics ............................................................................................................................... 32 
Results ..................................................................................................................................... 33 
Paper 1 ................................................................................................................................. 33 
Paper 2 ................................................................................................................................. 33 
Paper 3 ................................................................................................................................. 34 
Discussion ................................................................................................................................ 36 
Disease Characteristics Predicting Interest in Genetic Risk Information .................... 38 
Individual Characteristics Predicting Interest in Genetic Risk Information ............... 39 
Research Limitations ......................................................................................................... 44 
Ecological validity. ......................................................................................................... 44 
Measurement issues. ....................................................................................................... 47 
Conclusions ......................................................................................................................... 49 





This research was financially supported by the National Programme for Research in 
Functional Genomics (FUGE) of the Norwegian Research Council. Without the infrastructure 
and the people of the research group, the Bergen Psychosocial FUGE-project, this work 
would have been impossible. Karin Nordin and Wibecke Brun were my supervisors during 
the entire project period. I want to thank you Karin, for your support and your confidence in 
me. Wibecke, thank you for your help, honesty, and friendship.  
To my friends at the faculty, Siri, Kristin, and Evelyn, without you this experience 
would have been so much more miserable! To my parents, Ursel and Gerd, thank you for 
always treating me with the right mixture of ridicule and admiration. To my husband, José, 
thank you for all the weekends you spend alone watching the kids, and thank you for (almost) 
always providing a shoulder to cry on. To my children, Anna and Jakob, you’re just the 
sweetest little monsters, providing me with the right perspective on work and life in general. 
 8
 9
List of Papers. 
 
Paper 1 
Wolff, K., Nordin, K., Brun, W., Berglund, G., & Kvale, G. (in press). Affective and 
cognitive attitudes, uncertainty avoidance and intention to obtain genetic testing: An 
extension of the Theory of Planned Behaviour. Psychology and Health  
 
Paper 2 
Wolff, K., Brun, W., Kvale, G., & Nordin, K. (2007). Confidentiality versus duty to inform—
An empirical study on attitudes towards the handling of genetic information. American 
Journal of Medical Genetics Part A, 143A(2), 142–148. doi:10.1002/ajmg.a.31467 
 
Paper 3 
Wolff, K., Brun, W., Kvale, G., Ehrencrona, H., Soller, M., & Nordin, K. (in press). How to 
handle genetic information - A comparison of attitudes among patients and the general 




Progress in the field of molecular genetics has made it possible to identify individuals 
with an increased risk for a variety of hereditary diseases. To ensure successful 
implementation of genetic testing and counselling according to patients best interests the 
attitudes and motives behind testing intentions are important to consider. The main aim of the 
current thesis was to investigate factors which might facilitate the uptake of genetic testing. 
Furthermore this research investigated whether potential relatives want to be informed about 
the existence of hereditary conditions within their family, and under which conditions they 
want healthcare providers to breach confidentiality in order be informed. Finally, the thesis 
compares the attitudes of patients with hereditary conditions within their family to the 
attitudes of the general public concerning these issues. It was hypothesized that interest in 
receiving genetic risk information would be influenced by both characteristics of the 
individual and by characteristics of the disease. The role of disease characteristics was studied 
by using scenarios with systematically varied disease features, namely fatality, treatability and 
penetrance. Individual factors were investigated by using an extended version of Ajzen’s 
(1985; 1991) Theory of Planned Behaviour, as well as several individual difference measures 
such as uncertainty avoidance, worry, coping, self-efficacy, consideration for future 
consequences, knowledge about genetics, and familiarity with genetic testing. Results showed 
interest in learning about ones genetic risk to be relatively high, as was the acceptance of 
confidentiality breaches. Among the predictors the most important disease characteristic was 
the treatability of the disease, and the most important individual predictor was uncertainty 
avoidance. Patients were found to be more positive towards receiving genetic risk information 






Genetic tests include a variety of laboratory techniques to determine whether a person 
has a hereditary condition or disease, or is likely to develop one. Tests can be used to confirm 
a diagnosis (diagnostic testing), to establish whether a couple is at risk of having a child with 
a genetic disorder (carrier testing), or to detect changes in a fetus's genes or chromosomes 
before birth (prenatal testing). The current thesis focuses on predictive testing, also called 
presymptomatic or susceptibility testing, i.e. genetic testing used to determine whether a 
symptom free individual has an increased risk of developing a genetic disorder later on in life.  
Currently more than a 1000 tests for different genetic conditions are available, many of which 
are very rare. For the time being tests are mainly offered to individuals with a family history 
of certain diseases, in later years, however, genetic testing services are becoming available to 
everybody over the internet. To ensure successful implementation of genetic testing at the 
population level and to promote counseling according to patients best interests the attitudes 
and motives behind testing intentions are important to consider. Some limited research 
attention has been directed toward estimating interest in genetic testing and actual test taking 
behaviour. These studies show a fairly high interest in predictive testing for hereditary 
cancers, ranging from 32% (Bunn, Bosompra, Ashikaga, Flynn, & Worden, 2002) up to 90% 
(Bosompra, Ashikaga, Flynn, Worden, & Solomon, 2001), and a somewhat lower interest for 
diseases such as Huntington’s disease (Binedell & Soldan, 1997) or Alzheimer’s disease 
(Frost, Myers, & Newman, 2001). However, less is known about the motivating factors 
behind these test taking intentions. More knowledge about these factors could improve 
counseling as well as the accuracy of estimates of upcoming and changing demands for 
genetic testing services.  
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Genetic information differs to some extend from other medical information in that it is 
personal, sensitive, familial, and potentially discriminatory. Genetic testing reveals risk 
information not only about the individual but also about the individual’s family members. 
Patients who test positive for a disease causing mutation are strongly encouraged to inform 
their family, so that testing can be offered to all at-risk relatives, and the disease can either be 
prevented or the prognosis improved by early detection. The existence of this sensitive 
personal- yet at the same time familial- information raises new ethical and legal questions 
(Falk, Dugan, O'Riordan, Matthews, & Robin, 2003; Wertz & Fletcher 1989; 1991). One 
dilemma is how to protect the individual’s right not to know this information. Another 
questions concerns health care providers’ rights and possibly obligations to disclose this 
information to at-risk relatives. In the assumingly rare cases where patients fail to disclose 
risk information to family members, healthcare professionals face an ethical dilemma between 
the principle of confidentiality on one side, and the duty to warn at-risk individuals on the 
other. This problem is particularly pressing for physicians caring for several members of the 
same family (Chan-Smutko, Patel, Shannon, & Ryan, 2008).  
The question of confidentiality versus duty to warn has been discussed in the literature 
and there is some limited empirical research looking at patients and professionals attitudes 
towards the issue. In the medical ethics literature a spectrum of opinions about the stringency 
of confidentiality exists, ranging from commentators focusing on the sensitivity of genetic 
information, calling for more stringent confidentiality measures, on one end of the spectrum 
(e.g. Denbo, 2006; McGuire et al., 2008), to others focusing on the non-individualistic cohort 
ownership of genetic information questioning the practice of withholding information from 
potentially affected family (e.g. Taub, Morin, Spillman, Sade, & Riddick, 2004; Gilbar, 2007) 
on the other end. Regarding empirical research, findings show that the vast majority of 
patients perceive it to be their duty to inform their family (d'Agincourt-Canning 2001; Wilson 
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et al. 2004), and most patients do in fact disclose their genetic status to relevant family 
members (Clarke et al. 2005). Research on family communication about risk for Huntington 
Disease shows that some patients pursue genetic testing solely to provide risk information to 
other family members (Etchegary & Fowler, 2008) whilst others decline testing out of fear 
that a positive test result would be harmful to family members (d’Agincourt-Canning, 2006). 
With regard to health care providers attitudes, there seems to be little consensus as to which 
circumstances call for confidentiality breaches (Wertz, Fletcher, & Mulvihill, 1990). Findings 
also show that about half of all clinicians have faced the dilemma of patients refusing to 
inform family members in their practice; and about ¼ has seriously considered informing at-
risk relatives against their patient’s wishes. Cases where clinicians actually do inform 
relatives without consent are rare, despite the fact that the majority of clinicians (63 to 69%) 
believe they have an obligation to ensure that at-risk relatives are being informed (Clarke et 
al. 2005; Dugan et al. 2003; Falk et al. 2003).  
The situation to date remains challenging. Clinicians are facing the dilemma of 
whether or not to warn at-risk relatives, but there is little consensus or established practise on 
how to tackle the issue. The lack of research looking at whether or not relatives actually want 
to be informed is therefore striking. To my knowledge there are heretofore no empirical 
studies looking at whether potential relatives want to be informed about the existence of 
hereditary conditions within their family, and under which conditions they want healthcare 
providers to breach confidentiality to inform them. It is important to investigate, not only the 
attitudes of the general population, but also attitudes among affected groups, i.e. people with 
an increased risk for hereditary diseases. This is because affected groups constitute a minority 
within the general public. Public opinion, however, might have a decisive influence on an 




The present research set out to study the predictors and motivating factors of 
intentions to undergo genetic testing. Furthermore, it investigated whether and under which 
conditions people want to be informed about the existence of hereditary condition within their 
family. And finally it compared the attitudes of individuals who have experience with genetic 
conditions within their family (i.e. patients with an increased risk for hereditary cancer) to 
attitudes of the general public regarding these questions. Interest in ones genetic risk status is 
likely to be predicted by both characteristics of the individual and by characteristics of the 
disease, and even by the interplay between the two. Therefore the research to be presented in 
this thesis investigates the role of disease characteristics by using hypothetical scenarios with 
systematically varying disease characteristics; as well as the role of individual characteristics 
by using an extended version of Ajzen’s (1985; 1991) Theory of Planned Behaviour (TPB) 
and several individual difference measures.  
 
On Attitudes 
In order to be able to study the effect of different disease characteristics in 
combination with individual characteristics, hypothetical scenarios were employed throughout 
this research. This implies that the dependent variables of the current research can not be 
measures of actual genetic testing behaviour, but are measures of attitudes and intentions 
towards genetic testing and towards being informed about the existence of hereditary 
conditions within ones family. Attitudes are usually conceptualized to include both an 
affective and a cognitive evaluation of an object as well as a behavioural tendency towards the 
object. Most modern definitions of the attitude concept are unidimensional, including an 
evaluation of the attitude object which is both cognitive and affective, but excluding 
behaviour from the definition of attitude (e.g. Eagly & Chaiken, 1993; Petty, Wegener & 
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Fabrigar, 1997). Attitudes are commonly found to predict behaviour moderately well (e.g. 
Glasman & Albarracín, 2006). 
The research presented in the current thesis employed Ajzens (1985, 1991) 
operationalization of the attitude concept, which defines an attitude as a cognitive and 
affective evaluation of a given behaviour, which is separate from, but predictive of the 
intention to perform that behaviour. While the affective evaluation is a defining component of 
an attitude, according to Ajzen (1985, 1991, 2002), his model, the Theory of Planned 
Behaviour (TPB), has still been criticized for not assessing this component sufficiently 
(Manstead & Parker, 1995; Richard, van der Pligt, & de Vries, 1995). The present research 
therefore tried to extend the TPB (Ajzens, 1985, 1991) by incorporating a measure of the 
affective attitude component. 
 
Individual Characteristics Predicting Interest in Genetic Risk Information 
Potential individual predictors were assessed using an extended version of Ajzen’s 
(1985; 1991) Theory of Planned Behaviour (TPB) as well as several individual difference 
measures. The TPB is an expectancy-value model designed to predict and explain human 
behaviour in specific contexts (Ajzen, 1985, 1991). Its utility in predicting and explaining 
intentions as well as actual behaviour has been demonstrated in a number of health-related 
behaviours including genetic testing intentions (Nordin, Bjork & Berglund, 2004). The model 
depicts intention as the direct antecedent of behaviour. Intentions are in turn determined by 
attitudes, subjective norms, and perceived behavioural control. Attitudes are an individual’s 
evaluation of the behaviour as either positive or negative, subjective norms represent the 
individual’s perceived social pressure to perform the behaviour, and perceived behavioural 
control refers to the individual’s perception of control over performing the behaviour. The 
model also specifies the antecedents of attitudes and subjective norms. For any given attitude 
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these are a small set of specific salient behavioural beliefs, i.e., anticipated outcomes of the 
behaviour, weighted by an evaluation of each of these outcomes. Correspondingly the 
antecedents of subjective norm are a set of beliefs about how others want one to behave 
weighted by ones willingness to comply with these wishes (Ajzen, 1985, 1991).  
 




















A recent meta-analysis (Cooke & French, 2008) examining the models ability to 
predict intentions to attend screening programs (including genetic screening) as well as actual 
attendance in such programs found large sized relationships between attitudes and intentions, 
and medium sized relationships between intentions and actual attendance behaviour. The 
relationships of subjective norm and perceived behavioural control with intentions were also 
medium sized. 
 Despite the success of the TPB in predicting various behaviours, a substantial 
proportion of variance in health related behaviours remains unexplained. One possible 
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shortcoming of the TPB is its lacking focus on affective processes, in that it tends to 
emphazise cognitive or instrumental outcomes of behavioural actions (Manstead & Parker, 
1995; Richard et al., 1995). However anticipated affective outcomes may be as important as 
instrumental outcomes in determining attitudes and intentions. Studies that have extended the 
TPB by measures of anticipated affective outcomes, especially anticipated regret, have been 
successful in increasing the predictive power of the model across different behaviours (see 
e.g. Parker, Manstead, Stradling, & Reason, 1992; Richard, de Vries, & van der Pligt, 1998; 
Abraham & Sheeran, 2004). A meta-analysis by Cooke and Sheeran (2004) found affective-
cognitive consistency to moderate attitude-behaviour consistency, and reviewing the research, 
Conner & Armitage (1998) concluded that there is evidence supporting the inclusion of 
anticipated affective outcomes into the TPB-model. A more recent meta-analysis by Rivis, 
Sheeran, and Armitage (2009) found that the inclusion of anticipated affect increased the 
variance explained in intentions by 5%.  
The relative lack of affective outcomes in the TPB may possibly be caused by the 
method used to elicit anticipated outcomes, namely by asking for advantages and 
disadvantages of a given behaviour. This might sample a predominantly cognitive subset of 
anticipated outcomes and fail to elicit beliefs which are more difficult to articulate, like e.g. 
affective outcome expectations (Conner & Armitage, 1998).  In the present research the TPB 
was therefore extended to also include anticipated affective outcomes of the behaviour, i.e. 
affective behavioural beliefs.   
Other individual difference measures employed in this research include measures of 
uncertainty avoidance, worry, coping, self-efficacy, consideration for future consequences, 
knowledge about genetics, and familiarity with genetic testing. Uncertainty avoidance as a 
possible motivator for genetic testing emerged in research on test uptake for Huntington’s 
disease. Women who considered increased certainty as an advantage of genetic testing were 
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found to be more positive towards obtaining a test (Decruyenaere, Evers-Kiebooms, & Van 
den Berghe, 1993). Similarly Braithwaite, Sutton, and Steggles (2002) found that uncertainty 
avoidance predicted intention to be tested for hereditary cancer. Croyle, Dutson, Tran and Sun 
(1995) found women high in Need for Certainty to report greater interest in genetic testing, 
however when provided with additional information about the remaining cancer risk for 
women testing negative, they were less interested in obtaining a test. The opposite pattern was 
found for women low in Need for Certainty. Henderson, Maguire, Gray, and Morrison (2006) 
also found that the desire to resolve ambiguity motivated some of their participants to pursue 
genetic testing. The present research hypothesised that individuals high in uncertainty 
avoidance would be more interested in genetic testing. However, while the research discussed 
above used broad personality type measures to assess the concept of uncertainty avoidance, 
the current research employed a scale developed in the specific context of medical testing, 
where uncertainty avoidance is construed as a situation specific attitudinal measure 
(Braithwaite, Sutton, & Steggles, 2002). This measure is more specific than a personality 
measure, which in accordance with Ajzen’s (1988) principle of compatibility should increase 
its predictive power.  
Increasing amounts of research have shown that disease related worry may motivate a 
variety of health behaviours (Cameron, 2003). Worry has for example been associated with 
mammogram use (Diefenbach, Miller & Daly, 1999) and testicular self-examinations (Katz, 
Meyers & Walls, 1995). Cameron and Reeve (2006) found worry to be associated with 
perceived benefits of breast cancer testing. In fact, worry moderated the relationship of 
perceived benefits with testing interest, i.e. when worry was high interest was high regardless 
of the level of perceived benefits. This suggests that disease related worry is a strong 
motivator to undergo genetic testing even when benefits are limited. According to the DSM-
IV (1994), worry is a key component of anxiety, and is characterized by a tendency to view 
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ambiguous or uncertain situations as threatening (Butler & Matthews, 1987). Worrying may 
even be used as a form of arousal control or problem solving strategy (Miceli & Castelfranchi, 
2005). Since individuals who view the reduction of uncertainty as an advantage were found to 
be more positive towards genetic testing it was hypothesised that people high in trait worry, 
which prefer to avoid uncertainty, would be more positive towards receiving genetic risk 
information. Accordingly, the present research aimed at assessing the role of trait worry, as 
opposed to earlier employed measures of disease specific - or state - worry. 
Even though uncertainty reduction and increased information search are usually 
thought of as means of reducing anxiety; there also exists research (see e.g. Pifalo, Hollander, 
Henderson, DeSalvo, & Gill, 1995) showing that a minority of responders experiences 
increased anxiety after receiving medical information, and some people might in fact actively 
avoid receiving such information (Decruyenaere et al., 1993). Findings by Zuuren and Dooper 
(1999) show that individuals high in monitoring, i.e. seeking information and confronting 
threats, were more likely to engage in disease detection behaviour, while the effect of 
blunting, i.e. avoiding information, was unclear. Reviewing the literature on information 
seeking, uptake of genetic testing, and coping strategies, Case, Andrews, Johnson, and Allard 
(2005) point to the importance of studying information avoidance. The present study therefore 
investigates whether wanting to be informed about the existence of genetic conditions within 
ones family are negatively related to avoidant coping. The employed measure of coping style 
incorporates a three factor structure of coping, i.e. task-focused, emotion-focused, and 
avoidant coping, which possibly reflects the underlying dimensions of coping better then 
earlier to-dimensional taxonomies (e.g. Milller, 1987 monitoring vs. blunting; Folkman & 
Lazarus, 1980 problem-focused vs. emotion-focused; Endler & Parker, 1990; McWilliams, 
Cox, & Enns, 2003). 
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Perceived control is conceptualized as a determinant of behaviour by many health 
behaviour models (Conner & Norman, 1996; Rutter & Quine, 1994) and research has shown 
that people who perceive to have control over their lives are more likely to engage in health 
promoting behaviours (Norman, Bennett, Smith, & Myrphy, 1998). Perceived behavioural 
control as conceptualized by Ajzen’s (1985, 1991) TPB-model is one example of such a 
control construct. One of the most prominent control constructs is self-efficacy, defined as an 
individual’s belief in her capability to muster the cognitive, motivational and behavioral 
recourses required to produce given attainments (Bandura, 1997). According to Bandura 
(1997), self-efficacy (like perceived behavioural control) is a situation-specific, 
contextualized, and state-like belief in ones competence which is based on personal 
experience with the behaviour. Specific self-efficacy has been found to predict various health 
behaviors (Strecher, DeVellis, Becker, & Rosenstock 1986), including intentions to screen for 
dementia (Galvin, Fu, Nguyen, Glasheen, & Scharff, 2008) and perceived benefits from 
cancer genetic testing (Manne et al., 2007). Research suggests that repeated experiences of 
failure or success may develop into a generalized, trait-like belief in ones ability to deal with 
life in general, which is carried forward into new situations (Wallston, Wallston, Smith, & 
Dobbins, 1987; Hendy, Lyons, & Breakwell, 2006). Leganger and Kraft (2003) have shown 
that such general self-efficacy can mediate the relationship between higher socioeconomic 
status and health behaviours. Taking a genetic test is a novel situation for most individuals, 
and it is therefore unlikely that many have developed situation specific self-efficacy in this 
domain. Study two therefore aimed at examining whether general self-efficacy would predict 
intentions to undergo genetic testing. 
The degree to which behavioural choices are influenced by an individual’s time 
perspective or by a consideration for the potential future outcomes of a decision may differ 
from one person to the next. Strathman, Gleicher, Boninger, and  Edwards (1994) have 
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defined such individual differences in the “Consideration for Future Consequences” (CFC) as 
“the extent to which people consider the potential distant outcomes of their behaviour and the 
extent to which they are influenced by these potential outcomes” (Strathman et al., 1994, p. 
737). The concept is extensively employed and is primarily assessed by the CFC-scale. CFC 
has been found to influence and predict a wide variety of phenomena, including health-related 
behaviors, like decisions concerning HIV screening (Dorr, Krueckeberg, Strathman, & Wood, 
1999). Orbell, Perugini, and Rakow (2004) found that individuals who considered immediate 
rather than distant consequences where more positive towards colorectal cancer screening 
when it had short term positive and long term negative consequences. The opposite pattern 
was found for participants high in CFC.  In the current thesis it was therefore hypothesized 
that individuals who consider distant as opposed to immediate consequences when making 
decisions would be more positive towards learning about their potential genetic risk. 
Findings concerning the effect of having more knowledge about genetics and being 
aware of the possibility of genetic testing are rather inconsistent in previous research. Studies 
have found knowledge to be both related (Jallinoja & Aro, 2000; Thompson, Valdimarsdottir, 
Jandorf, & Redd, 2003) and unrelated (Lipkus, Iden, Terrenoire, & Feaganes, 1999; Kinney et 
al., 2001) to interest in genetic testing. The same is true for familiarity with genetic testing (no 
relation: Bunn et al., 2002; significant relation: Satia, McRitchie, Kupper, & Halbert, 2006). 
The present research assessed both knowledge about genetics and familiarity with genetic 
testing in order to try and clarify the issue. 
 
Disease Characteristics Predicting Interest in Genetic Risk Information 
Instead of only investigating test interest for specific diseases, it is important to try to 
disentangle which disease characteristics motivate test-taking in general. This will make it 
possible to more accurately estimate the demand for genetic testing services for diseases 
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where characteristics have changed (e.g. from fatal to non-fatal, or from non-treatable to 
treatable) and for diseases with given characteristics where testing becomes available for the 
first time. In addition to examining the influence of the individual characteristics described 
above, the present research therefore investigates the effect of three disease characteristics, 
namely treatability, fatality, and penetrance (i.e. the probability of getting ill in case one is a 
mutation carrier) on interest in receiving genetic risk information.  
The treatability and/or preventability of a disease are well established predictors of 
test taking interest (e.g. Roberts, 2000; Shaw & Bassi, 2001). The fatality of a disease is one 
of its major characteristics, and a prominent indicator of its severity and as such a potentially 
important predictor of test taking interest. Penetrance is the probability of getting ill in case 
one is a mutation carrier. Penetrance may be low for some diseases (e.g. 10%) and close to 
certain for others (up to 100%). Increased penetrance has been found to increase test interest 
(Frost et al., 2001). It is also possible that disease characteristics interact with each other or 
with individual preferences to influence test taking interest. Findings by Wang, Gonzalez, 
Janz, Milliron, and Merajver (2007) showed for example that individuals who perceived their 
own susceptibility to be high but the severity of breast cancer to be low were more likely to 
pursue genetic testing than all other susceptibility/severity combinations. As mentioned 
earlier, findings by Croyle and colleagues (1995) point to the possibility that people with a 
preference for uncertainty might be more interested in genetic testing for diseases with low 
penetrance.  
The duty to warn at risk relatives about their potential genetic risk is also strongly 
influenced by the characteristics of the disease. It increases as the probability that relatives 
will be affected increases, the disease becomes more serious, and the disease is preventable or 
harm is reducible by early detection. Confidentiality guidelines in most countries take this 
into account and allow breaches of confidentiality only for diseases that meet these criteria 
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(ASHG, 1998; Godard, Hurlimann, Letendre, Égalité & INHERIT BRCAs, 2006). In terms of 
the disease characteristics varied in this research it means that test interest and acceptance for 
confidentiality breaches might be higher for diseases that are highly penetrant, fatal and 
treatable. 
 
To sum up the present research aims at illuminating the role of individual and disease 
characteristics in predicting intentions to undergo genetic testing, willingness to receive 
genetic risk information from relatives, and acceptance of confidentiality breaches by health 
care personnel in order to be informed about ones genetic risk. The research also aims at 
comparing the attitudes of affected individuals, i.e. people with hereditary conditions in their 
family, to the attitudes of the general public on these issues.  
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Methods 
In order to be able to investigate attitudes in large samples and be able to directly 
compare attitudes across different samples, the research presented in this thesis primarily 
relied on survey method. Questionnaires describing systematically varied disease scenarios 
were collected in different samples in Norway and Sweden, including individuals from the 
general population, patients and students. Individual difference measures were used to 
investigate the effect of individual predictors on interest in receiving genetic risk information. 
In order to avoid tiring research participants with long questionnaires, different individual 
difference measures were employed during separate data collections. This makes it of course 
impossible to compare samples on the assessed concepts, it allows however for the study of a 
greater variety of possible predictors. 
 
Participants and Procedure 
Paper 1 aimed to investigate predictors for intentions to obtain a genetic test for 
hereditary diseases with varying characteristics within the general population. A random 
sample of the Norwegian population (N = 2400) between the ages of 18 to 65 received a 
questionnaire and one reminder in the mail. The final response rate was 36.4%, resulting in a 
total of 874 participants, of which 46.2% were male, the mean age was 41.7 (SD = 12.8), and 
41.0% had university education. Four hypothetical disease scenarios were constructed by 
systematically varying two disease characteristics: fatality (fatal vs. non-fatal) and penetrance 
(50% vs. 100% penetrance). All diseases were described as incurable. The design was cross-
sectional; only one disease scenario was randomly assigned to each participant. This resulted 
in four versions of the questionnaire. 
Paper 2 investigated under which conditions participants from the general population 
want to be informed about the existence of hereditary conditions within their family, and 
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whether they want health care providers to breach confidentiality in order to be informed. The 
study includes three samples. The first sample is the same Norwegian random sample as in 
Paper 1 (N = 2400). The second sample is a comparable Swedish sample, randomly drawn 
from the population between the ages of 18 to 75 (N = 1200). Participants were mailed a 
questionnaire and three reminders. A total of 665 completed questionnaires were returned, 
constituting a response rate of 55.4% of which 47.4% were male, the mean age was 44.3 (SD 
= 15.5), and 28.5% had a university education. By varying three disease characteristics 
(fatality, penetrance, and treatability) four hypothetical scenarios were constructed: 1. Fatal, 
non-treatable disease with 50% penetrance. 2. Fatal, non-treatable disease with 100% 
penetrance. 3. Non-fatal, treatable disease with 50% penetrance. 4. Non-fatal, treatable 
disease with 100% penetrance. One scenario was randomly assigned to each participant.  
The third sample is a convenience sample of students from the University of Bergen, 
Norway (n = 607). Data were collected during lecture breaks in introductory psychology and 
natural science courses. Response rates were very high, about 90%, 34.3% were male and the 
mean age was 21.2 (SD = 4.6). The same three disease characteristics as in the Swedish 
random sample were varied, constructing all eight possible disease scenarios. One disease 
scenario was randomly assigned to each participant. 
Paper 3 aimed at investigating attitudes towards the handling of genetic information in 
an affected group, i.e. people with an increased risk for hereditary cancers, and compared 
them to the attitudes of the general population. The study includes 2 groups: patients and 
individuals from the general population. The general population sample consists of the three 
subsamples described in Paper 2, i.e. the Norwegian random sample, the Swedish random 
sample and the Norwegian student sample. The patient sample consist of individuals that 
underwent genetic counselling for suspected hereditary cancers at the University hospitals in 
Lund or Uppsala (Sweden, N = 408), or the University hospital in Bergen (Norway, N = 414). 
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Everyone over age 18 who underwent genetic counselling at one of these institutions during 
2005 was mailed a questionnaire and one (Norway) / two (Sweden)1 reminders. Response 
rates were 73.5% in the Swedish sample and 52.4% in the Norwegian sample, resulting in a 
total of 517 participants, 15.4% were male, mean age was 48.0 (SD = 12.35). The same three 
disease characteristics as described above, i.e. fatality, penetrance, and treatability, were 
systematically varied, and all eight possible disease scenarios were constructed. The design 
was cross-sectional; only one scenario was randomly assigned to each participant. 
 
Measures 
Constructs belonging to the TPB (i.e., intentions, behavioural beliefs, subjective norm, 
and perceived behavioural control) assessed in Paper 1 were measured in accordance with 
Ajzen’s (2002) suggestions. 
Dependent variables. 
Intention to undergo genetic testing (Paper1). Participants were asked to imagine that they 
had a close relative with one of the above mentioned diseases. Following a brief description 
of the disease participants answered two questions. First: “Would you be interested in taking a 
genetic test if you had to take the initiative for being tested yourself?” and second: “Would 
you be interested in taking a genetic test if your physician suggested it?” Answers were given 
on 7-point semantic differential scales anchored by very unlikely(1)-very likely(7). Scores of 
one and two were coded as not intending to test and scores of six and seven as intending to 
test.   
                                                 
1 The different numbers of reminders which were sent to samples in Sweden and Norway throughout the studies 
presented here are due to the fact that Norwegian ethics committees allow for only one reminder to be sent to 
research participants while Swedish committees do not pose any limitations. This explains the greater response 
rates observed in the Swedish samples. Before sending out reminders response rates are comparable in the 
Swedish and Norwegian samples in all studies. The difference in number of reminders was controlled for by 
entering this variable into the first block of the regression analysis in all studies. No effect was found in any of 
the studies. 
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Desire to be informed (Papers 2 and 3). Participants were asked to imagine that they had a 
close relative who tested positive for a hereditary disease. Following a description of the 
disease all participants answered three questions on 7-point scales all anchored by agree 
completely(1)–disagree completely(7): (1) “I want my relative to tell me that he/she is a 
carrier of the disease causing mutation.” (2) “I want the physician to contact and inform me 
even if my relative is against it.” (3) “I do not want to be informed if one of my close relatives 
has this hereditary disease.” Items one and two were reversed in the analysis. In Paper 2 items 
one and three were averaged to constitute a measure of “desire to be informed by the 
relative”. In Paper 3 only question one was used as an indicator of “desire to be informed by 
the relative”. Question three was dropped from the analysis because many participants of the 
patient sample answered it inconsistently, i.e. not noticing that its meaning is opposite to that 
of question one. Item two was used to indicate “desire to be informed against the relatives’ 
wishes” in both papers. Scores of two or less were coded as not wanting to be informed and 
scores of six or more were coded as wanting to be informed with or without the relative’s 
consent respectively. 
 Predictor variables 
Attitudes (Paper1). Belief based measures were used to assess both attitude and subjective 
norm. Anticipated outcomes of genetic testing were mapped by semi structured interviews in 
a pilot study. Content analysis of the interviews yielded 14 different anticipated outcomes. 
Five additional outcomes which were to reflect affective outcomes were added to the final 
questionnaire. Participants judged the probability and the desirability of each anticipated 
outcome using 7-point semantic differential scales. Corresponding items on both scales were 
multiplied to constitute belief based measures of attitude. Exploratory factor analysis 
(varimax rotation) of the multiplied items yielded four meaningful factors, labelled Negative 
consequences ( = .79), Positive consequences ( = .66), Information ( = .68), and Future 
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effects ( = .56). Items loading on each respective factor were summed to constitute believe 
based measures of attitude. 
Subjective norm (Paper 1). Responses to two questions were given on 7 -point semantic 
differential scales: (1) “Do you believe that the following people would want you to undergo a 
genetic test…?” (2) “…will you take these people’s opinion into consideration?” Each 
question was followed by a list of eight persons (husband/wife, children, parents, siblings, 
grandparents, friends, physician, and the media). All scales were anchored by no, absolutely 
not(1)-yes, absolutely(7). Corresponding scores on question one and two were multiplied. The 
resulting eight items displayed high internal consistency ( = .90), and were summed to 
construct an index of subjective norm. 
Perceived behavioural control (Paper1).  Four questions were answered using 7-point 
semantic differential scales: (1) “For me to have a genetic test would be… very difficult(1)-
very easy(7)”, (2) “If I wanted to I would manage to have the test taken.”, anchored by 
disagree completely(1)-completely agree(7) (3) “It is up to me whether or not I will have a 
test like that” disagree completely(1)-completely agree(7), and (4) “How much control do you 
believe you have over undergoing a test like that?” anchored by no control(1)-complete 
control(7). Responses to these questions were summed in order to construct an index of 
perceived behavioural control ( = .54).  
Uncertainty avoidance (Papers 1, 2, and 3). The Attitude toward Uncertainty scale 
(Braithwaite et al., 2002), was used to assess the tendency to avoid uncertainty in the specific 
context of medical testing. The scale consists of 8 items and responses are given on a 5-point 
scale ranging from strongly disagree(1) to strongly agree(5). The composite measure was 
computed as the mean of all items (after reversing two items). High scores indicate a 
preference to avoid uncertainty. Paper 1:  = .88; M = 3.28, SD = .98; Paper 2:  = .89, M = 
3.33, SD = 1.04; Paper 3:   = 90, M = 2.51, SD = 1.05 
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Knowledge about genetics (Paper 2) was measured by seven self-constructed statements 
about genetics and heritability. Participants indicated whether they believed the statements to 
be true or false, or whether they were uncertain. Correct (+1), incorrect (-1), and “don’t 
know” (0) responses were summed to constitute a measure of knowledge about genetics (M = 
3.64, SD = 2.13). Respondents gave on average 4.23 (SD = 1.83) correct and 0.59 (SD = .78) 
incorrect answers. 
Familiarity with genetic testing2 (Papers 2 and 3) was measured on a single item by having 
participants indicate how much they had heard about genetic testing for hereditary diseases. 
The 5-point scale was anchored by I have never heard of it(1)- I know a bit about it(3)-I am 
well informed about it(5). Paper 2: M = 2.55; SD = .82; Paper 3: M = 2.73, SD = 1.02. 
Self-efficacy (Paper 2) was assessed using the Generalized Self-efficacy scale (Schwarzer & 
Jerusalem, 1995), which consists of 10 items measuring the general belief that one can 
perform a novel or difficult tasks, or cope with adversity in various domains. Responses are 
given on 4-point scales and summed to constitute a composite measure ( = .88; M = 3.02, SD 
= .43). High scores indicate high self-efficacy. Self-efficacy was assessed in the Swedish 
general population sample only. 
Worry (Paper 2) was assessed using the Penn State Worry Questionnaire (Meyer, Miller, 
Metzger, & Borkovec, 1990), which is a 16-item self-report measure of trait worry. Responses 
were given on 5-point scales and summed to constitute a composite score ( = 92; M = 2.42, 
SD = .78). High scores indicate greater worry. Worry was measured only in the Swedish 
general population sample. 
Coping Style (Paper 3). Coping style was measured using the 30-item Coping Style 
Questionnaire, CSQ-30 (Joseph, Williams, & Yule, 1992) which assesses subjects’ style of 
coping with a specific event on three dimensions: task focused-, emotion focused-, and 
                                                 
2 This construct is labeled “Knowledge about genetic testing” in the published version of paper 2. One of the 
reviewers of paper 3 suggested however that it more correctly should be labeled “Familiarity with genetic 
testing”. For consistency this label is used throughout the thesis.  
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avoidant coping. Responses are given on 4-point scales and three sum scores are computed to 
constitute measures of task focused- ( = .66; M = 26.86, SD = 3.65), emotion focused- ( = 
.60; M = 24.24, SD = 3.72), and avoidant ( = .58; M = 19.05, SD = 3.46) coping respectively. 
High scores indicate the presence of the given coping style. Coping style was assessed in the 
patient sample only. 
Consideration for Future Consequences, CFC (Paper 3). This was assed with the 12-item 
CFC-questionnaire (Strathman et al., 1994). Responses are given on 5-point scales and 
summed to constitute a composite measure ( = .75; M = 39.08, SD = 3.67). High scores 
indicate a tendency to consider distant rather than immediate consequences of behavioural 
decisions. CFC was only measured in the patient sample. 
 
Statistics 
Two-way ANOVA was used to compare mean scores of the intention to test take a 
genetic test for the four different disease scenarios of Paper 1. One-way ANOVA 
(Bonferroni) and independent sample t-tests were used to compare mean scores of the desire 
to be informed for the different diseases in Paper 2. In Paper 3 one-way ANOVA (Bonferroni) 
and Mann-Whitney U tests were used to compare the desire to be informed for the different 
scenarios. Wherever multiple comparisons where made, a significance level of p < .001 was 
applied. Regression analysis was used to check for a possible interaction effect between 
uncertainty avoidance and penetrance. 
To analyze the influence of demographic and other individual difference variables, 
block wise multiple regression analyses were performed. Regression analysis was used to 
check for a possible interaction effect between uncertainty avoidance and penetrance. 
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Results 
The intention to obtain a genetic test was relatively high in the Norwegian general 
population, and across all samples the desire to be informed about the existence of a 
hereditary disease within one’s family was also quite high. So was the acceptance of 
confidentiality breaches. Among the predictors the most important disease characteristic was 
the treatability of the disease, and the most important individual predictor was uncertainty 
avoidance. Patients were found to be even more positive towards being informed by a relative 
and towards breaches of confidentiality then the general population. 
 
Paper 1 
The study aimed at investigating predictors for the intention to obtain a genetic test for 
hereditary diseases with varying characteristics within the general population. Intentions to be 
tested were relatively high across all disease scenarios, varying between 40 and 63%. 
Intentions were greater for highly penetrant diseases, and when testing was suggested by the 
physician. Fatality did not influence test taking intentions. The most important individual 
predictor was uncertainty avoidance. The extended TPB model predicted intentions to 
undergo genetic testing moderately well, explaining about 11% of the variance (10% when 
the test is suggested by the physician). The attitude factors labelled Negative consequences 
and information were significant predictors. So was subjective norm. The interaction term for 
penetrance and uncertainty avoidance was insignificant. 
 
Paper 2 
This paper investigated whether individuals from the general population wanted to be 
informed about the existence of hereditary diseases within their family, and under which 
conditions they wanted health care providers to breach confidentiality in order to be informed. 
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The Norwegian general population sample, the Swedish general population sample, and the 
student sample were analyzed separately. The desire to be informed was quite high in all 
samples and for all diseases. Between 52 and 83% of participants stated that they wanted to be 
informed by their relative, depending on sample and disease characteristics. Only between 0 
and 13% stated that they did not want to be informed. The proportions of participants wanting 
to be informed against their relatives’ wishes were significantly lower, but still quite high, 
ranging from 18 to 54%. Between 11 and 36% of participants opposed breaches of 
confidentiality. The desire to be informed both with and without the relatives consent was 
greater for treatable compared to non-treatable conditions, and for fatal compared to non-fatal 
diseases in cases where the relative did not consent. Penetrance did not influence the desire to 
be informed. The disease that fulfils all ASHG (1998) criteria as to when confidentiality 
breaches might be permissible displayed the greatest support for confidentiality breaches, i.e. 
the disease that is highly penetrant, fatal and treatable. Individual characteristics which 
predicted the desire to be informed by the relative were first and foremost uncertainty 
avoidance, but also female gender, younger age, and having or planning for children. Wanting 
to be informed against the relatives’ wishes was predicted by uncertainty avoidance, Swedish 
nationality, higher age, by less knowledge about genetics, and by less self-reported familiarity 
with genetic testing. Self-efficacy and worry did not predict the desire to be informed. 
 
Paper 3 
The purpose of this study was to investigate attitudes towards the handling of genetic 
information in an affected group, i.e. people with an increased risk for hereditary cancers, and 
compare those to attitudes of the general public. In this study the Norwegian general 
population sample, the Swedish general population sample, and the student sample were 
combined to constitute the general population sample. The desire to be informed by a relative 
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was quite high, ranging between 65 and 82% in the general population, and even higher 
between 83 and 94% in the patient sample depending on the disease scenario. The proportions 
of participants not wanting to be informed by their relative were relatively small, between 3 
and 10% in the general population and 0 and 8% in the patient sample. Main effects were 
found for sample and treatability, i.e. patients were more interested in being informed than the 
general population, and the desire to be informed was greater for treatable than non-treatable 
diseases. The interaction term was also significant showing that the difference in desire to be 
informed found between the general population and patients was greater for non-treatable 
compared to treatable diseases.  
The desire to be informed without the relatives consent was significantly lower, 
ranging between 25 and 46% in the general population and between 58 and 75% in the patient 
sample. Proportions of participants opposing confidentiality breaches ranged between 22 and 
36% in the general population and between 7 and 27% in the patient sample. There was a 
main effect for sample, with patients being more positive towards confidentiality breaches, 
and a significant interaction effect for sample and treatability, indicating that the difference 
found between patients and general population is greater for non-treatable diseases.  
While the general populations desire to be informed both with and without the 
relatives consent was greater for treatable compared to non-treatable diseases, the patient 
samples desire to be informed was completely unaffected by the characteristics of the disease. 
Individual predictors for the desire to be informed by the relative were uncertainty avoidance, 
female gender, and having or planning for children in the general population. In the patient 
sample the only predictor was uncertainty avoidance. The desire to be informed against the 
relatives’ wishes was predicted by uncertainty avoidance, Swedish nationality, higher age, 
and by less self-reported familiarity with genetic testing in the general population; and by 
uncertainty avoidance and Swedish nationality in the patient sample.  
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Discussion 
Approximately half of the Norwegian general population sample wanted to obtain a 
genetic test even for an incurable disease. A clear majority of both the patient sample and the 
overall general population sample wanted to be informed by a relative about the existence of a 
hereditary condition within their family, and patients preferred so to an even higher degree 
than the general population. In fact, there is a ceiling effect in the patient sample, illustrated 
by mean scores well above 6 (maximum score being 7) for all disease scenarios. Willingness 
to be informed against the relatives’ wishes was significantly lower, but still quite high, with 
up to half of the participants of the overall general population sample, and up to ¾ of the 
patients, supporting breaches of confidentiality.  
Findings clearly show that interest in receiving genetic risk information is quite high 
in all samples and for all disease scenarios. These findings are in line with other research 
showing high interest in genetic testing (e.g. Bosompra et al., 2001; Satia et al., 2006). The 
fact that patients report a greater desire to be informed about disease causing mutations than 
the general population is hardly surprising. After all, this sample was selected on the basis of 
having received genetic counselling in the past, i.e. they had already demonstrated their desire 
to learn about hereditary conditions in their family. However, the extent of positivity towards 
receiving genetic risk information expressed among patients might be considered somewhat 
surprising. It may be illustrative of the experience responders had with receiving such genetic 
risk information in the past: The vast majority does not show signs of regretting having 
learned about their genetic risk, and states that they would choose to do so again in the future. 
Together with the possible health advantages of knowing ones carrier status, these findings 
might be interpreted as support for the common practice of encouraging patients to inform at 
risk family members.  
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It is also interesting to note that patients, much more clearly than the general 
population, support confidentiality breaches. This is true despite the fact that many of them 
have been in the position of the patient who has to disclose information to family members 
and whose confidentiality would be breached, in the described situation. Possibly, this finding 
may be interpreted as an illustration of the fact that most patients understand the importance 
of, and perceive it to be their duty to inform family members about, their carrier status 
(d'Agincourt-Canning, 2001; Wilson et al., 2004). 
The proportions of participants explicitly stating that they do not want to receive 
genetic risk information are small. In the Norwegian general population sample no more then 
¼ of participants did not want to obtain a genetic test, at least not for an incurable disease. The 
proportions of participants that did not want to be informed about their genetic risk by a 
relative were even smaller, maximally 13% in the overall general population sample, and 
maximally 8% among patients depending on the characteristics of the disease. Proportions of 
participants opposing confidentiality breaches reached 36% in the overall general population 
sample, and 27% among patients.  
Again, together with the advantages of knowing about an increased health risk, 
findings support the practice of encouraging patients to inform at risk family. However, 
although the numbers of participants that do not want to know their genetic risk are small, 
they are not insignificant. These findings are in line with other research showing that there are 
individuals who do not want to learn about an increased genetic risk. A review by Gaff et al., 
(2007) found that some patients had difficulties communicating with relatives, due to adverse 
reactions by some family members. Kenen, Ardern-Jones and Eeles (2004) also found that 
some individuals actively tried to avoid receiving genetic risk information from their relatives, 
e.g. by hanging up the phone or refusing to answer questions. If one is to take the right not to 
know seriously, it is important to try and find ways of not spreading information to 
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individuals who do not welcome it. At the very least it might be time to encourage individuals 
to discuss the issue with their family and inform others about whether and under which 
condition they want or do not want to be informed about hereditary diseases within their 
family.  
 
Disease Characteristics Predicting Interest in Genetic Risk Information 
Different disease characteristics had some influence on the participants’ willingness to 
learn about ones genetic risk status. In the Norwegian general population sample intentions to 
obtain a genetic test were greater for diseases with high penetrance compared to diseases with 
low penetrance. This difference in test taking intentions was however no longer significant 
when the test was suggested by a physician. Even though survey research has demonstrated 
this difference (e.g. Frost et al., 2001), the present findings may suggest that it might not 
generalize to settings where patients rely on their physician’s opinions to guide their decision 
making concerning genetic testing. Whether or not the disease was described as fatal did not 
influence intentions to be tested. It is important to note however that all diseases in the 
Norwegian general population sample were described as incurable, and that fatality might 
influence test taking intentions when the disease is treatable or preventable. (Note that since 
all diseases were described as incurable in this sample, there are no data on the possible effect 
of treatability.)  
When it comes to being informed about the existence of a hereditary condition within 
the family, there was an effect of treatability, with the general population being more 
interested in being informed about treatable than non treatable diseases both with and without 
their relatives consent. This is in line with other research showing greater interest in genetic 
testing for treatable diseases (e.g. Roberts, 2000; Shaw & Bassi, 2001). In the Norwegian 
student sample there was also an effect of fatality, with students showing greater desire to be 
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informed against the relatives’ whishes for fatal diseases. Patients’ desire to be informed was 
very high and completely unaffected by characteristics of the disease. This can possibly be 
explained by patients being influenced by the disease they have experience with, i.e. 
hereditary cancer (which most of the time is treatable), rather than by the hypothetical 
scenario described in the survey. The ceiling effect of the dependent variable among patients 
is another possible explanation. Treatability also diminished the difference found between the 
patients and the general populations desire to be informed with and without the relatives 
consent. This means that there is more agreement between the samples on the importance of 
being informed when diseases can be treated then when they can not. This is in line with 
guidelines described above in countries that allow for confidentiality breaches under certain 
circumstances (ASHG, 1998; Godard et al., 2006). Findings are also in line with an important 
point made by Evans and Burke (2008), that the more useful genetic information becomes the 
more it challenges the concept of genetic exceptionalism, and furthermore that the special 
protection of genetic information is important only for diseases that are not treatable. 
 
Individual Characteristics Predicting Interest in Genetic Risk Information 
Uncertainty avoidance was by far the most important individual predictor of intentions 
to obtain a genetic test and of the desire to be informed with and without the relatives consent. 
In all samples this variable had by far the strongest correlation of all predictor variables with 
the dependent variables. These findings are in line with previous findings by  Braithwaite et 
al. (2002) who found only one variable to predict test taking interest better than uncertainty 
avoidance, namely a direct measure of attitude, which was not employed in the present 
research. Findings clearly demonstrate that the desire to reduce uncertainty may be an 
important motivator for individuals wanting to learn their genetic risk status. In order to 
facilitate patients’ decision making and secure informed choice concerning genetic testing it is 
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therefore important to inform them about the remaining uncertainties, e.g. tests which are less 
then 100% accurate, incomplete penetrance or residual risks for individuals testing negative. 
In light of the problems lay people in general have regarding understanding and interpreting 
probabilities and risk information, this is a challenging aspect of providing health information 
and genetic counselling. 
It was expected that there would be an interaction effect between uncertainty 
avoidance and penetrance, i.e. participants high in uncertainty avoidance preferred to receive 
genetic risk information when the disease was high in penetrance, and participants low in 
uncertainty avoidance preferred this information when the disease was low in penetrance. 
This would have replicated findings by Croyle et al. (1995) showing that women who disliked 
uncertainty decreased their interest in genetic testing after being informed about its remaining 
uncertainties, while women preferring uncertainty increased their interest. No such interaction 
effect was found in any of the samples. Possibly participants did not understand the impact of 
penetrance on the degree of certainty of a genetic test result. This would explain why 
penetrance was not a more important predictor, even though uncertainty avoidance in itself 
seems to be very important to the participants. 
 
The intention to undergo genetic testing was assessed in the Norwegian general 
population sample, and intention was tried to be explained by an extended version of Ajzen’s 
(1985, 1991) Theory of panned behaviour. This extended version included measures of both 
cognitive and affective behavioural beliefs (i.e. outcome expectations), which fell into four 
factors labelled Negative consequences, Positive consequences, Information, and Future 
effects, as well as measures of subjective norm and perceived behavioural control. The 
employed TPB-model predicted intentions to undergo genetic testing only moderately well. 
The belief based attitudinal measures of the TPB contribute somewhat to the variance 
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explained in intentions. The factor Negative consequences is a significant predictor of test 
taking intentions when the participant has to initiate testing. It also predicts intentions when 
the physician suggests testing, but only until uncertainty avoidance is entered into the final 
model. This implies that participants who perceive the consequences of genetic testing to be 
less negative have stronger intentions to obtain a test. Furthermore Information is a significant 
predictor when the physician suggests testing, until uncertainty avoidance is entered into the 
model. In other words, participants who expect to receive more information, and who value 
this information positively, are more likely to intend to obtain a genetic test.  It is worth 
noticing that Negative consequences is the only attitudinal factor which is comprised of 
mainly affective outcome expectations. Since the factor is a predictor of intention, findings 
point to the possible importance of including affective outcome expectations into the 
attitudinal measures of the TPB. This is in line with earlier quoted findings (Parker et al., 
1992; Richard et. al, 1998; Abraham & Sheeran, 2004) showing that the inclusion of affective 
outcomes can increase the models predictive power. Findings are also in line with Lawton, 
Conner and McEachan (2009) who, using direct measures of attitude, found that affective 
attitudes where a stronger predictor than cognitive attitudes for 9 out of 14 health related 
behaviours.  
The employed measure of uncertainty avoidance construes the concept as an 
attitudinal measure. Since it is such a strong predictor of intention one wonders why it was not 
mentioned in the pilot interviews conducted to map salient belief based attitudes for the TPB-
questionnaire. Possibly the reduction of uncertainty, together with affective outcomes belongs 
to a subset of behavioural beliefs which are not readily accessed by the commonly employed 
method of asking for advantages and disadvantages of a given behaviour (Conner & 
Armitage, 1998). Since these non-cognitive beliefs are potentially important predictors of 
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intentions and behaviour, future research should address the question of how to elicit such 
beliefs among informants. 
The TPB component subjective norm also contributes somewhat to the amount of 
variance explained in both measures of intention; however this effect disappears when 
uncertainty avoidance is entered into the model. It is somewhat surprising that subjective 
norm does not have a stronger influence on interest in test taking in our sample, especially 
since the results of a genetic test have a direct impact on family members. However the 
possibility of having genetic tests is rather new and participants might not be aware of how 
significant others feel about them having a genetic test. This would mean that there still does 
not exist any social pressure or subjective norm in this domain, and while filling in the 
questionnaire, participants simply assume that friends and family feel the same way they do. 
This would explain both the very high internal consistency of the measure ( = .90) and why 
it does not influence test taking interest in this study.  
The TPBs perceived behavioural control component did not predict test taking 
intentions. According to Ajzen (1991) perceived behavioural control is a construct which is 
useful for predicting intentions especially in situations where participants feel that the 
behaviour is difficult to control. Examples of these kinds of behaviours are quitting to smoke, 
exercising regularly or refraining from having unsafe sex. These are behaviours that need to 
be performed continuously in order to be beneficial, whilst having a genetic test is a one-time 
behaviour. Hence obtaining a genetic test might be considered a behaviour that is easy to 
control, which might be the reason that perceived behavioural control did not predict testing 




The desire to be informed by a relative about the existence of a hereditary condition 
within the family was assessed both in the general population in Norway and Sweden as well 
as among patients from both countries. As discussed earlier, the main predictor of the desire 
to be informed was uncertainty avoidance in all samples. In the general population other 
predictors were female gender, younger age, and having or planning for children. These 
effects were small however. In the patient sample uncertainty avoidance was the only 
significant predictor, explaining only minimal amounts of variance. This is probably due to 
the ceiling effect of the dependent variable among patients. 
When it comes to being informed against the relatives’ wishes, again the main 
predictor was uncertainty avoidance. In the general population additional predictors were 
Swedish nationality, higher age, less knowledge about genetics, and less self-reported 
familiarity with genetic testing. These effects were also small. Among patients the only 
predictor besides uncertainty avoidance was Swedish nationality.  
Results indicate that increasing people’s knowledge about genetics and their 
familiarity with genetic testing might reduce their acceptance of confidentiality breaches. 
Together with the finding that uncertainty avoidance motivates genetic testing, the fact that 
knowledge about testing decreases interest indicates that participants may overestimate the 
degree of certainty that genetic testing can provide. Again this illustrates the importance of 
informing the general public about the remaining uncertainties of genetic testing. Possibly this 
might also reduce their acceptance of confidentiality breaches. However looking at the degree 
of positivity towards confidentiality breaches among the participants most familiar with 
genetic testing, i.e. patients, this is far from certain.  
The fact that Swedish participants, both general population and patients, were more 
positive towards confidentiality breaches than participants in Norway can possibly be 
explained by Sweden being the most liberal country in the EU and one of the most liberal 
 44
countries in the world as far as access to documents is concerned (Österdahl, 1998). Sweden 
has the world's oldest freedom of information law, and views on public access of information 
as a human right (Davis, 1999). 
Other individual predictors that were assessed but did not predict the desire to be 
informed either with or without the relatives consent were Self-efficacy and worry in the 
general population of Sweden, and Coping style and Consideration for Future Consequences 
(CFC) among patients in Sweden and Norway. Because Coping style and CFC were assessed 
in the patient sample only, and because this sample displayed a ceiling effect in the dependent 
variable it is difficult to conclude that these variables are not related to interest in receiving 
genetic risk information. Future research, using samples with greater diversity of responses, 
will have to illuminate this question.  
The fact that Self-efficacy did not predict desire to be informed by a relative is in line 
with findings described in Paper 1, showing that perceived behavioural control did not predict 
intentions to undergo genetic testing. As discussed earlier, possibly having a genetic test, or 
receiving genetic risk information is not viewed as difficult to control or to perform by 
participants. This might of course be due to the fact that the situation is hypothetical for most 
participants from the general population.  
The finding that trait worry was unrelated to desire to be informed might indicate that 
the desire to reduce medical uncertainty which seems to motivate genetic testing is not related 
to a general tendency to worry.  
 
Research Limitations  
Ecological validity. 
One limitation of this research is the rather low response rates especially in the general 
population samples. Inspection of the sample demographics shows that higher education and 
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female gender are overrepresented amongst the participants. Furthermore it is unfortunate that 
the samples also differ from each other in demographic characteristics and in survey 
administration, e.g. number of reminders received. By comparing participants who responded 
immediately to participants who responded after receiving a reminder on the depended 
variables (i.e. intention to undergo a genetic test and desire to be informed) the possible effect 
of the number of reminders was examined. Also demographic variables, as well as the number 
of reminders received before answering, were entered into the first block of the regression 
analyses in order to control for their effect on the dependent variables. Findings revealed that 
these variables wield minimal to no influence. Group differences are therefore unlikely to be 
caused by differences in sample demographics or survey administration. This implies that the 
findings probably can be generalized even though the samples’ demographic characteristics 
might not be entirely representative of their respective populations. How non-responders 
might have responded and how they differ from participants is a recurring problem of all 
survey research, including the current work, regardless the size of the response rates. 
However while the proportions of respondents stating that they want to receive genetic risk 
information may be affected by the response rates, there is less reason to assume that the 
pattern showing different levels of interest for different diseases would be very much affected, 
that individual predictors would be different, or that there would be a higher degree of 
consensus regarding the issue of confidentiality. 
 The use of individuals who have received genetic counselling to represent the at-risk 
population is another problem regarding the ecological validity of the current research. This 
group has been selected on the basis of their previous interest in genetic information and may 
thus be a special sub-sample not entirely representative of the at-risk population in general. 
Ethical and legal considerations make it difficult, if not impossible, to recruit a representative 
at-risk sample in a different manner, and for the time being one will have to live with this 
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shortcoming in order to be able to make the comparison between general population and at-
risk individuals. It is also worth noticing that even though the entire patient sample had 
received genetic counselling, not everybody chose to go ahead with genetic testing.  The 
overwhelming positivity amongst these patients is not self-evident and hence interesting to 
note, although a more representative at-risk sample or the entire at-risk population might 
display somewhat less positive attitudes.  
Hypothetical disease scenarios have been employed throughout the research presented 
in this thesis. To what extent the respondents perceived the scenario descriptions as realistic, 
and hence responded in accordance with their “real” attitudes and reactions, is therefore 
uncertain. The use of hypothetical scenarios also implies that attitudes and intentions were 
measured instead of actual genetic testing behaviour. This does of course imply some 
limitations to the generalizeability of the findings as research shows that the relationship of 
attitudes and intentions with behaviour are often only moderate (Glasman & Albarracín, 2006; 
Cooke & French, 2008). Several factors have been shown to influence the attitude-behaviour 
relation. For example are attitudes a stronger predictor of behaviour when they are based on 
consistent or one-sided information and on direct experience with the behaviour (see e.g. 
Glasman & Albarracín, 2006). In study one participants where confronted with both positive 
and negative outcomes of genetic testing, and in all three studies presented here only the 
patient sample had direct experience with receiving genetic risk information. Therefore one 
might be somewhat pessimistic about how representative the assessed attitudes and intentions 
are of actual test taking behaviour. The often found discrepancy between high self-reported 
intentions and much lower actual test uptake (Binedell & Soldan, 1997) may certainly apply 
to this research as well. One can therefore speculate that actual test taking behaviour will be 
lower in a real life setting, and future research will have to examine the relations between 
predictors of test taking intentions with actual testing behaviour. However, as discussed 
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above, while the proportions of supporters and opposers of receiving genetic risk information 
might be affected by the limitations of this research, predictors are less likely to be affected. 
It should also be noted that the use of hypothetical scenarios has advantages. Only the 
use of diseases with systematically varied features makes it possible to study the effect of 
disease characteristics and their possible interaction with individual differences. Furthermore, 
using non-specific diseases ensures that the participants’ decisions are influenced by relevant 
disease characteristics like treatability, rather than by less relevant characteristics like the 
familiarity of any specific disease. One might even argue that the result’s generalizeability 
increases by the use of hypothetical diseases. This is because it becomes possible to infer the 
relative degree of test interest for different conditions depending on how these conditions rank 
on the three characteristics that have been manipulated, i.e. fatality, penetrance and 
treatability.  
Furthermore, it is in fact impossible to ask someone the question of whether they want 
to be informed about the existence of a hereditary disease within their family for any specific 
disease without already making the essence of that information known to the person (Wertz & 
Fletcher, 1991). On a general or hypothetical level, however, it is possible to ask if, and under 
which conditions, someone would be interested in knowing whether they are at risk. If one is 
to take patients’ right of choice seriously, this is, in fact, the only way to grant this right.  
Measurement issues. 
The employed measures of individual differences vary in their degree of specificity. 
While some of them constitute broad personality measures, like e.g. general self-efficacy, 
others are much more specific attitudinal measures, like the measure of uncertainty avoidance. 
According to Ajzen’s (2002) principle of compatibility, in order to find strong correlations 
between variables, all constructs need to be defined in terms of the same elements regarding 
specificity, context, and time. While having a genetic test is a rather specific behavior, 
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generalized Self-efficacy and trait worry are very general measures. This is another possible 
explanation for why the results did not show a relation between these variables and the desire 
to be informed about genetic conditions within ones family, while more specific measures like 
disease related worry (Cameron, 2003) and specific Self-efficacy (Strecher et al., 1986) have 
been found to be associated with health related behaviours. The compatibility principle may 
also partly explain why the employed measure of uncertainty avoidance was such a strong 
predictor, compared to all other variables. The relation between uncertainty avoidance (as 
measured by the Attitude towards Uncertainty-scale; Braithwaite et al., 2002) and test taking 
intention as well as the desire to be informed in the current research is interesting to observe 
and in line with findings by others (e.g. Decruyenaere et al., 1993; Croyle et al., 1995). 
However, it will be important in the future to study how this measure relates to more general 
trait measures of uncertainty avoidance and interest in genetic risk information. 
The ceiling effect observed in the patients desire to be informed is problematic and a 
clear limitation of this research. This methodological problem makes it difficult, if not 
impossible, to make any conclusive inferences about the possible predictive value of the 
measures employed in this study, i.e. Consideration for future consequences and Coping style. 
Future research may work to construct a more nuanced and sensitive dependent variable to be 
able to further examine the role of these concepts in predicting interest in receiving genetic 
risk information. 
Another limitation of the thesis is that samples to a certain extend have been “reused” 
in different papers. While this is cost efficient, it results in smaller sample size and, may be 
more importantly, one also misses the opportunity of replicating findings which could have 
increased confidence in the conclusions. It is however interesting to note that participants 
from samples who differ in sample selection method and demographic characteristics, like 
e.g. student sample and randomly drawn population samples, still are very similar in their 
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responses to whether and under which conditions they want to receive genetic risk 
information. This clearly supports the generalizeability of the findings and conclusions. 
It may also be argued that it is also somewhat unfortunate that all studies have used the 
same method of data collection, i.e. questionnaires using hypothetical scenarios. Therefore 
findings may have been influenced by common method variance (Campbell & Fiske, 1959), 
which may artificially inflate the correlations between variables assessed by the same method. 
This may weaken the certainty with which conclusions can be drawn from this research. The 
advantage of using the same method was however the possibility to directly compare affected 
and non-affected groups.  
 
Conclusions 
Whether knowing that one has an increased genetic risk really is a health advantage 
depends on whether or not it actually leads to necessary behaviour change. This is of course 
an empirical question beyond the scope of this thesis. Let it be mentioned, however, that 
research indicates that it might, at least for some people lead to these changes (see e.g. 
Sanderson, Humphries, Hubbart, Hughes, Jarvis, & Wardle, 2008; Claassen, Henneman, 
Kindt, Marteau, & Timmermans, 2010). Possible negative psychological impacts of knowing 
that one is a mutation carrier has also not been a subject of this thesis; research seems to 
indicate however that there do not seem to be long term negative emotional consequences of 
testing positive (see e.g. Meiser et al., 2008; Green et al., 2009; Kaphingst & McBride 2010). 
Knowing that one is not a mutation carrier (which will be the case for the majority of people 
undergoing genetic testing) is of course an indisputable advantage. It brings relief from 
possible worry and frees one from undergoing possibly harmful screening procedures.  
The present thesis found participants to be interested in receiving genetic risk 
information and they displayed a relatively high acceptance of confidentiality breaches. 
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Patients were even more positive towards receiving information than the general population. 
The main individual predictor in all samples was uncertainty avoidance; the most important 
disease characteristic was treatability. Findings support the common practice of encouraging 
patients to inform relevant family members about their increased genetic risk. Still there are 
some participants both in the general population and among patients who state that they do 
not want to receive such information. If one is to take their right of not knowing seriously, it 
will be necessary to find ways to protect them from this unwanted information. Findings also 
showed that it will be important to inform the public about the remaining uncertainties of 
genetic testing in order to facilitate informed choice and to avoid possible misconceptions 
about the degree of certainty genetic testing can provide.  
Furthermore, findings point to the possible importance of including affective outcome 
expectations into the attitudinal measures of the TPB. The present research also found that 
asking informants about the possible advantages and disadvantages of genetic testing did not 
elicit all belief based attitudes which predicted intentions in the TPB-model. Future research 
might find a better way to elicit less assessable attitudes like e.g. affective outcomes which 
might further increase the predictive power of the model. 
Finally, current legislations in both Norway and Sweden specifically forbid physicians 
to breach confidentiality in order to inform at risk relatives. The majority of foreign 
jurisdictions (World Medical Association, World Health Organization, Council of Europe, 
Nuffield Council on Bioethics, Health Council of the Netherlands, Privacy Commissioner of 
Australia) are taking a different stance. While maintaining that confidentiality must be 
ensured and protected, they allow limited disclosure of genetic test results without the patients 
consent in cases where the harm to at-risk relatives is grave and imminent, and the 
information could result in effective intervention (ASHG, 1998; Godard et al., 2006). The 
findings of the current thesis show that the attitudes of both the general population and 
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certainly of the people concerned, i.e. patients with an increased risk for hereditary conditions, 
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